It’s impossible to talk about cancer without realizing that everybody’s life has been touched by it either directly or indirectly. In the United States, half of women and one-third of men will be afflicted with cancer in their lifetime, and it still ranks as the second leading cause of all death, only a hair behind atherosclerosis.

But unlike heart disease, cancer lethality is even greater in mid-life than among seniors. In fact, for people between the ages of 45 to 65, cancer is the leading cause of death, killing more people than heart disease, liver disease, and stroke combined.

When thinking about how to prevent mortality from cancer, there are three key questions to consider: 

  1. (1) How do you prevent cancer? 
  2. (2) How do you screen for cancer to detect it early? 
  3. (3) How do you treat it when you have it?

Below is a collection of clips, podcasts, and articles discussing the latest science on cancer prevention, treatments, and the importance of cancer screening.


Peter on the importance of cancer screenings

This video clip is from AMA #25: Navigating the complexities and nuances of cancer screening, originally released on July 26,…

Can a peptide found in bee stings offer hope for treatment-resistant breast cancers?

Melittin, the main component of honeybee venom, has shown promise as a basis for chemotherapeutic drugs to combat treatment-resistant breast cancer

#267 ‒ The latest in cancer therapeutics, diagnostics, and early detection | Keith Flaherty, M.D.

Early detection is going to allow our same toolbox of drugs to be massively more effective.” —Keith Flaherty

#252 ‒ Latest insights on Alzheimer’s disease, cancer, exercise, nutrition, and fasting | Rhonda Patrick, Ph.D.

My perspective has shifted as any scientist that’s following data should… When new data comes out, you have to reassess things.” —Rhonda Patrick

cancer mrna vaccine

Antitumor mRNA vaccines are cause for optimism

Moderna recently announced preliminary results of a clinical trial involving a personalized antitumor mRNA vaccine, and despite the knee-jerk uproar, the treatment may prove to be another useful weapon in the battle against cancer

colonoscopy research

Confusion over results of a recent colonoscopy trial

A recently published NEJM paper appears to show that colonoscopy screenings do not reduce risk of colorectal cancer death. As is often the case, the results have been taken out of context and their implications grossly overestimated.

#216 – Metabolomics, NAD+, and cancer metabolism | Josh Rabinowitz, M.D., Ph.D.

“My big hope is that we’re going to be able to have some combination of directed, metabolic immune supplements and diet that really work with therapy to treat cancer.” —Josh Rabinowitz

Fighting cancer and improving immune function with sleep

This audio clip is from episode #48 with Matthew Walker, Ph.D., on sleep – Part II of III: Heart disease,…

#213 ‒ Liquid biopsies and cancer detection | Max Diehn, M.D. Ph.D.

I was frustrated by not being able to diagnose a recurrence earlier.” —Max Diehn

Cumulative effects of LDL-C reduction in mitigating cardiovascular risk

Atherosclerotic cardiovascular disease (ASCVD) is currently the leading cause of death in the U.S. One of the most effective ways to reduce risk of ASCVD mortality is reduction of apoB particle number, typically estimated by LDL cholesterol (LDL-C) concentrations.

Facebook icon Twitter icon Instagram icon Pinterest icon Google+ icon YouTube icon LinkedIn icon Contact icon